Related Experiment Videos
Unintentional pediatric superwarfarin exposures: do we really need a prothrombin time?
M E Mullins1, C L Brands, M R Daya
1Oregon Poison Center, Department of Emergency Medicine, Oregon Health Sciences Center, Portland, Oregon, USA. mullinsm@msnotes.wustl.edu
Pediatrics
|February 2, 2000
Summary
Routine follow-up coagulation tests are not necessary for children with accidental superwarfarin rodenticide exposure. These children, including those exposed to superwarfarin compounds, did not experience bleeding or require vitamin K treatment.
Area of Science:
- Pediatric Toxicology
- Emergency Medicine
- Pharmacovigilance
Background:
- Superwarfarin rodenticides are common household products.
- Accidental pediatric exposures necessitate understanding of potential toxic effects.
- Coagulation monitoring is standard for anticoagulant exposure.
Purpose of the Study:
- To evaluate the necessity of routine follow-up coagulation studies in children with accidental superwarfarin rodenticide exposure.
- To determine if medical intervention is required following such exposures.
Main Methods:
- Retrospective chart review of pediatric superwarfarin exposures.
- Data collected from a regional poison control center over two 2-year periods.
- Outcome measures included prothrombin times (PT), international normalized ratios (INR), and clinical signs of bleeding.
Main Results:
- No significant coagulation abnormalities were detected in 542 children studied.
- None of the children developed bleeding complications.
- No child required vitamin K antidotal treatment.
Conclusions:
- Routine follow-up laboratory studies are not indicated for children with unintentional acute superwarfarin rodenticide exposure.
- Medical intervention, including vitamin K, is generally not required.
- This finding supports a less interventionist approach for minor exposures.